A biotechnology company developing RNA technologies to shape the future of gene therapy
Shape Therapeutics has raised $112.0M in total funding. The most recent round was Series B. The last funding was announced in July 2021.
Shape Therapeutics's investors include New Enterprise Associates, Cherubic Ventures, Decheng Capital, Mission BioCapital, CureDuchenne Ventures.
Shape Therapeutics is headquartered in Seattle, United States.
A biotechnology company developing RNA technologies to shape the future of gene therapy
Shape Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Shape Therapeutics — Funding & Investors." VCBacked, July 15, 2021, https://www.vcbacked.co/company/shape-therapeutics. Accessed July 21, 2026.
VCBacked. (2021). Shape Therapeutics — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/shape-therapeutics
{{cite web |title=Shape Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/shape-therapeutics |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated